FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
Equinix, Inc. (EQIX) Investor Alert: Grabar Law Investigates Claims as Securities Fraud Class Action Survives Motion to Dismiss
WHY: A recently filed federal securities fraud class action complaint against Equinix, Inc. (NASDAQ: EQIX) and certain of its officers has survived Defendants' motion to dismiss the complaint. Grabar ...
Equinix, Inc. (EQIX) Reports 7% Revenue Growth in Q3, Expands AI Infrastructure Partnerships with NVIDIA and Dell
Peter Oppenheimer, the chief of global equity strategy and the head of macro research for Goldman Sachs in Europe, opined ...
Zacks.com on MSN4d
Equinix (EQIX) Rises Higher Than Market: Key Facts
Equinix (EQIX) ended the recent trading session at $922.13, demonstrating a +1.53% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 0.53%.